The Metrix blog
The reimbursement landscape just changed. Does your FRM team know what to tell their accounts?
Access is a critical driver of both launch success and long-term growth. When reimbursement rules shift, the…
Metrix's top picks
Building field access capability from the ground up: Lessons from a launch-ready team
Field access has quietly become one of the most important levers in a successful launch. Yet in many organizations, it still doesn’t receive the same structured capability investment as sales or medical. That gap shows up in familiar ways: teams can recite the reimbursement landscape but struggle to execute consistently in the field. They “know”…
What keeps NSM strategy alive once the field is back to work?
The ballroom is full. The strategy is clear. The energy…
Why AI makes us more human in training
In life sciences, the most impactful learning experiences don’t just…
Agility in action: How pharma teams can thrive through disruption
Change isn’t coming to pharma, it’s already here. Product lifecycles are shorter. Access challenges…
Stay ahead of the game with regular updates
All results
The reimbursement landscape just changed. Does your FRM team know what to tell their accounts?
Access is a critical driver of both launch success and long-term growth. When reimbursement rules shift, the…
Building field access capability from the ground up: Lessons from a launch-ready team
Field access has quietly become one of the most important levers in a successful launch. Yet in…
What keeps NSM strategy alive once the field is back to work?
The ballroom is full. The strategy is clear. The energy is high. National Sales Meetings do exactly…
Why AI makes us more human in training
In life sciences, the most impactful learning experiences don’t just transfer knowledge; they create confidence, empathy, and…
Agility in action: How pharma teams can thrive through disruption
Change isn’t coming to pharma, it’s already here. Product lifecycles are shorter. Access challenges are steeper. Market disruptions, mergers and acquisitions,…
Why pharma training needs a new playbook for rare disease
The rare disease sector is no longer a niche. Nearly half of all new drug approvals in the U.S….
The experiential edge: Why learning by doing drives behavior change
If you’ve ever tried to learn to swim from a manual, you know it doesn’t work. You…
Storytelling with purpose: Using patient narratives to transform pharma training
In pharma, facts and data are everywhere. Clinical results, safety data, prescribing guidelines, these are essential, but…
Why intelligent personalization is the future of pharma L&D
In pharma, training has never been “one-size-fits-all.” Your sales rep in oncology needs a very different learning…
From learning to business impact: Closing the measurement gap in pharma training
Pharma leaders know training is a critical investment. Whether it’s onboarding new hires, preparing a field team for launch,…
From passive to performance: Our 4-step method to drive lasting behavior change
In pharma, knowing isn’t enough. Performance happens when knowledge turns into action and that’s where most training…
A smarter way to turn strategic priorities into measurable impact
In pharma, the stakes are high. Brand teams chase ambitious goals, while training teams are tasked with…